Jim has formed a company, Emphutos Therapeutics, to develop novel antiviral agents that target the host immunity pathway.

Congratulations to Mitchell Godin for being awarded a summer research fellowship (SURF) grant. Mitchell will be working on the mechanism of inhibition of PKR by viral noncoding RNAs.